REDUCED BLADDER CAPACITY IN PATIENTS RECEIVING INTRAVESICAL CHEMOPROPHYLAXIS WITH MITOMYCIN-C

被引：11

作者：

EIJSTEN, A ^{[1
]}

KNONAGEL, H ^{[1
]}

HOTZ, E ^{[1
]}

BRUTSCH, HP ^{[1
]}

HAURI, D ^{[1
]}

机构：

[1] UNIV HOSP ZURICH,DEPT UROL,CH-8091 ZURICH,SWITZERLAND

来源：

BRITISH JOURNAL OF UROLOGY | 1990年 / 66卷 / 04期

关键词：

D O I：

10.1111/j.1464-410X.1990.tb14959.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Summary— After complete resection of superficial bladder carcinoma (Tis‐2, G1‐3), 75 patients were treated prophylactically with either 20 or 30 mg mitomycin C. Six patients developed a substantial reduction in bladder capacity (less than 200 ml). In 2 patients radical cystectomy of an otherwise tumour‐free fibrotic bladder was necessary. The results of long‐term treatment (2 years) suggest that reduced bladder capacity correlates with the cumulative dosage of mitomycin C. © 1990 British Journal of Urology

引用

收藏

页码：386 / 388

页数：3

相关论文

共 10 条

[1] SEVERE BLADDER CONTRACTURE IN PATIENT RECEIVING INTRAVESICAL MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER [J].

BAKER, WC ;

RUSSO, MA ;

WHITE, RWD .

UROLOGY, 1987, 30 (04) :357-358

[2]

DENIS L, 1987, CANCER CHEMOTHER P S, V20, P67

[3] AN OVERVIEW OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER-TUMORS [J].

HERR, HW ;

LAUDONE, VP ;

WHITMORE, WF .

JOURNAL OF UROLOGY, 1987, 138 (06) :1363-1368

[4]

HULAND H, 1988, EUR UROL, V14, P202

[5] ADJUVANT CHEMOTHERAPY OF SUPERFICIAL TRANSITIONAL CELL BLADDER-CARCINOMA - PRELIMINARY-RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH ON TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN HYDROCHLORIDE, ETHOGLUCID AND TRANS-URETHRAL RESECTION ALONE-R [J].

KURTH, KH ;

SCHRODER, FH ;

TUNN, U ;

AY, R ;

PAVONEMACALUSO, M ;

DEBRUYNE, F ;

DEPAUW, M ;

DALESIO, O ;

TENKATE, F .

JOURNAL OF UROLOGY, 1984, 132 (02) :258-262

[6] TREATMENT OF RESIDUAL, NON-INFILTRATING BLADDER-CANCER WITH BACILLUS CALMETTE-GUERIN [J].

MORALES, A ;

OTTENHOF, P ;

EMERSON, L .

JOURNAL OF UROLOGY, 1981, 125 (05) :649-651

[7] SIDE-EFFECTS ASSOCIATED WITH INTRAVESICAL MITOMYCIN-C [J].

NISSENKORN, I ;

HERROD, H ;

SOLOWAY, MS .

JOURNAL OF UROLOGY, 1981, 126 (05) :596-597

[8]

RUBBEN H, 1988, UROLOGE A, V27, P152

[9] NATURAL-HISTORY AND TREATMENT OF LOW AND HIGH-RISK SUPERFICIAL BLADDER-TUMORS [J].

RUBBEN, H ;

LUTZEYER, W ;

FISCHER, N ;

DEUTZ, F ;

LAGRANGE, W ;

GIANI, G .

JOURNAL OF UROLOGY, 1988, 139 (02) :283-285

[10] TOPICAL MITOMYCIN-C THERAPY FOR CARCINOMA OF THE BLADDER [J].

STRICKER, PD ;

GRANT, ABF ;

HOSKEN, BM ;

TAYLOR, JS .

JOURNAL OF UROLOGY, 1987, 138 (05) :1164-1166